Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP425735.RAYgpF3lgNk4G52wQjgkrN1zZTLSP6Bl22YkpXQ6HvCPg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP425735.RAYgpF3lgNk4G52wQjgkrN1zZTLSP6Bl22YkpXQ6HvCPg130_assertion type Assertion NP425735.RAYgpF3lgNk4G52wQjgkrN1zZTLSP6Bl22YkpXQ6HvCPg130_head.
- NP425735.RAYgpF3lgNk4G52wQjgkrN1zZTLSP6Bl22YkpXQ6HvCPg130_assertion description "[We previously showed that a single intrapleural dose of an adenoviral vector expressing interferon-beta (Ad.IFN-beta) in patients with malignant pleural mesothelioma (MPM) or malignant pleural effusions (MPE) resulted in gene transfer, humoral antitumor immune responses, and anecdotal clinical responses manifested by modified Response Evaluation Criteria in Solid Tumors (RECIST) disease stability in 3 of 10 patients at 2 months and an additional patient with significant metabolic response on positron emission tomography (PET) imaging.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP425735.RAYgpF3lgNk4G52wQjgkrN1zZTLSP6Bl22YkpXQ6HvCPg130_provenance.
- NP425735.RAYgpF3lgNk4G52wQjgkrN1zZTLSP6Bl22YkpXQ6HvCPg130_assertion evidence source_evidence_literature NP425735.RAYgpF3lgNk4G52wQjgkrN1zZTLSP6Bl22YkpXQ6HvCPg130_provenance.
- NP425735.RAYgpF3lgNk4G52wQjgkrN1zZTLSP6Bl22YkpXQ6HvCPg130_assertion SIO_000772 20068553 NP425735.RAYgpF3lgNk4G52wQjgkrN1zZTLSP6Bl22YkpXQ6HvCPg130_provenance.
- NP425735.RAYgpF3lgNk4G52wQjgkrN1zZTLSP6Bl22YkpXQ6HvCPg130_assertion wasDerivedFrom befree-20140225 NP425735.RAYgpF3lgNk4G52wQjgkrN1zZTLSP6Bl22YkpXQ6HvCPg130_provenance.
- NP425735.RAYgpF3lgNk4G52wQjgkrN1zZTLSP6Bl22YkpXQ6HvCPg130_assertion wasGeneratedBy ECO_0000203 NP425735.RAYgpF3lgNk4G52wQjgkrN1zZTLSP6Bl22YkpXQ6HvCPg130_provenance.